Cinematherapy for Women With Depression and Anxiety

NCT ID: NCT06884033

Last Updated: 2025-08-12

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 30 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-01-15
• Study Completion Date: 2025-07-15

Brief Summary

Group cinematherapy program in reducing depressive and anxiety symptoms in women diagnosed with Depressive Disorders and Anxiety Disorders.

Detailed Description

Cinematherapy is a creative therapeutic intervention in which a trained professional prescribes the patient to watch a film and uses the characters and themes as metaphors to promote self-exploration and change. The effectiveness of cinematherapy as a therapeutic technique has been demonstrated through its effectiveness in improving participants' self-esteem, emotional expression and understanding, and interpersonal relationships, and in reducing depressive and anxious symptoms.The cinematherapy intervention involves a targeted selection of film content and activities designed to improve the patients' mental condition.The study includes eight meetings on a monthly basis (programming of eight films lasting approximately two hours and subsequent discussion on the contents of the film shown).

Conditions

Depression Anxiety Disorder

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Cinematherapy intervention

Cinematherapy intervention

Group Type: EXPERIMENTAL

Cinematherapy

Intervention Type: BEHAVIORAL

Cinematherapy, also known as cinema therapy and movie therapy, involves therapist-directed viewing of movies for specific therapeutic purposes.

Interventions

Cinematherapy

Cinematherapy, also known as cinema therapy and movie therapy, involves therapist-directed viewing of movies for specific therapeutic purposes.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• female, aged 18-75 years;
• Diagnosis of Depressive Disorders (unipolar and bipolar) and Anxiety Disorders according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM-5), both new onset in subjects without a previous psychiatric history, and depressive and anxious recurrences;
• Taking psychopharmacological therapy;
• Fluent knowledge of the Italian language;
• Release of a written informed consent, signed by the patient or legal representative and partner.

Exclusion Criteria

• Diagnosis of Schizophrenia or other psychotic spectrum disorders;
• Diagnosis of neurological disorders associated with cognitive decline;
• Current abuse of alcohol and psychotropic substances, with the exception of smoking;
• Refusal to sign the informed consent to participate in the study.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Marianna Mazza

Role: PRINCIPAL_INVESTIGATOR

Fondazione Policlinico Universitario A. Gemelli, IRCCS

Locations

Marianna Mazza

Rome, ROMA, Italy

Countries

Italy

Other Identifiers

7075

Identifier Type: -

Identifier Source: org_study_id